- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Gastrointestinal OTC Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Gastrointestinal OTC Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Gastrointestinal OTC Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Laxatives segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Gastrointestinal OTC Drugs include GlaxoSmithKline, Pfizer, Johnson & Johnson, Bayer, and Procter & Gamble, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gastrointestinal OTC Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Laxatives
Anti-Flatulents
H2-Antaginists
Anti-Diarrheals
PPIs
Anti-Emetics
Other
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global Gastrointestinal OTC Drugs market are listed below:
GlaxoSmithKline
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastrointestinal OTC Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastrointestinal OTC Drugs, with price, sales, revenue and global market share of Gastrointestinal OTC Drugs from 2019 to 2022.
Chapter 3, the Gastrointestinal OTC Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal OTC Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gastrointestinal OTC Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal OTC Drugs.
Chapter 13, 14, and 15, to describe Gastrointestinal OTC Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Gastrointestinal OTC Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastrointestinal OTC Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Laxatives
1.2.3 Anti-Flatulents
1.2.4 H2-Antaginists
1.2.5 Anti-Diarrheals
1.2.6 PPIs
1.2.7 Anti-Emetics
1.2.8 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastrointestinal OTC Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Gastrointestinal OTC Drugs Market Size & Forecast
1.4.1 Global Gastrointestinal OTC Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Gastrointestinal OTC Drugs Sales in Volume (2017-2028)
1.4.3 Global Gastrointestinal OTC Drugs Price (2017-2028)
1.5 Global Gastrointestinal OTC Drugs Production Capacity Analysis
1.5.1 Global Gastrointestinal OTC Drugs Total Production Capacity (2017-2028)
1.5.2 Global Gastrointestinal OTC Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gastrointestinal OTC Drugs Market Drivers
1.6.2 Gastrointestinal OTC Drugs Market Restraints
1.6.3 Gastrointestinal OTC Drugs Trends Analysis
2 Manufacturers Profiles
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Product and Services
2.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Gastrointestinal OTC Drugs Product and Services
2.2.4 Pfizer Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Product and Services
2.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Gastrointestinal OTC Drugs Product and Services
2.4.4 Bayer Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Procter & Gamble
2.5.1 Procter & Gamble Details
2.5.2 Procter & Gamble Major Business
2.5.3 Procter & Gamble Gastrointestinal OTC Drugs Product and Services
2.5.4 Procter & Gamble Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Perrigo
2.6.1 Perrigo Details
2.6.2 Perrigo Major Business
2.6.3 Perrigo Gastrointestinal OTC Drugs Product and Services
2.6.4 Perrigo Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Gastrointestinal OTC Drugs Product and Services
2.7.4 Abbott Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Gastrointestinal OTC Drugs Product and Services
2.8.4 Sanofi Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Teva Pharmaceutical
2.9.1 Teva Pharmaceutical Details
2.9.2 Teva Pharmaceutical Major Business
2.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Product and Services
2.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Nestle
2.10.1 Nestle Details
2.10.2 Nestle Major Business
2.10.3 Nestle Gastrointestinal OTC Drugs Product and Services
2.10.4 Nestle Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Boehringer Ingelheim
2.11.1 Boehringer Ingelheim Details
2.11.2 Boehringer Ingelheim Major Business
2.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Product and Services
2.11.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Reckitt Benckiser
2.12.1 Reckitt Benckiser Details
2.12.2 Reckitt Benckiser Major Business
2.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Product and Services
2.12.4 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Purdue Pharma
2.13.1 Purdue Pharma Details
2.13.2 Purdue Pharma Major Business
2.13.3 Purdue Pharma Gastrointestinal OTC Drugs Product and Services
2.13.4 Purdue Pharma Gastrointestinal OTC Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Gastrointestinal OTC Drugs Breakdown Data by Manufacturer
3 Gastrointestinal OTC Drugs Breakdown Data by Manufacturer
3.1 Global Gastrointestinal OTC Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Gastrointestinal OTC Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Gastrointestinal OTC Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Gastrointestinal OTC Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Gastrointestinal OTC Drugs Manufacturer Market Share in 2021
3.5 Global Gastrointestinal OTC Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Gastrointestinal OTC Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4 Market Analysis by Region
4.1 Global Gastrointestinal OTC Drugs Market Size by Region
4.1.1 Global Gastrointestinal OTC Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Gastrointestinal OTC Drugs Revenue by Region (2017-2028)
4.2 North America Gastrointestinal OTC Drugs Revenue (2017-2028)
4.3 Europe Gastrointestinal OTC Drugs Revenue (2017-2028)
4.4 Asia-Pacific Gastrointestinal OTC Drugs Revenue (2017-2028)
4.5 South America Gastrointestinal OTC Drugs Revenue (2017-2028)
4.6 Middle East and Africa Gastrointestinal OTC Drugs Revenue (2017-2028)
5 Market Segment by Type
5 Market Segment by Type
5.1 Global Gastrointestinal OTC Drugs Sales in Volume by Type (2017-2028)
5.2 Global Gastrointestinal OTC Drugs Revenue by Type (2017-2028)
5.3 Global Gastrointestinal OTC Drugs Price by Type (2017-2028)
6 Market Segment by Application
6 Market Segment by Application
6.1 Global Gastrointestinal OTC Drugs Sales in Volume by Application (2017-2028)
6.2 Global Gastrointestinal OTC Drugs Revenue by Application (2017-2028)
6.3 Global Gastrointestinal OTC Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7 North America by Country, by Type, and by Application
7.1 North America Gastrointestinal OTC Drugs Sales by Type (2017-2028)
7.2 North America Gastrointestinal OTC Drugs Sales by Application (2017-2028)
7.3 North America Gastrointestinal OTC Drugs Market Size by Country
7.3.1 North America Gastrointestinal OTC Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8 Europe by Country, by Type, and by Application
8.1 Europe Gastrointestinal OTC Drugs Sales by Type (2017-2028)
8.2 Europe Gastrointestinal OTC Drugs Sales by Application (2017-2028)
8.3 Europe Gastrointestinal OTC Drugs Market Size by Country
8.3.1 Europe Gastrointestinal OTC Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Gastrointestinal OTC Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Gastrointestinal OTC Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Gastrointestinal OTC Drugs Market Size by Region
9.3.1 Asia-Pacific Gastrointestinal OTC Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Gastrointestinal OTC Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10 South America by Region, by Type, and by Application
10.1 South America Gastrointestinal OTC Drugs Sales by Type (2017-2028)
10.2 South America Gastrointestinal OTC Drugs Sales by Application (2017-2028)
10.3 South America Gastrointestinal OTC Drugs Market Size by Country
10.3.1 South America Gastrointestinal OTC Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gastrointestinal OTC Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Gastrointestinal OTC Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Gastrointestinal OTC Drugs Market Size by Country
11.3.1 Middle East & Africa Gastrointestinal OTC Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Gastrointestinal OTC Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12 Raw Material and Industry Chain
12.1 Raw Material of Gastrointestinal OTC Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Gastrointestinal OTC Drugs
12.3 Gastrointestinal OTC Drugs Production Process
12.4 Gastrointestinal OTC Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gastrointestinal OTC Drugs Typical Distributors
13.3 Gastrointestinal OTC Drugs Typical Customers
14 Research Findings and Conclusion
14 Research Findings and Conclusion
15 Appendix
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Gastrointestinal OTC Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Gastrointestinal OTC Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Gastrointestinal OTC Drugs Product and Services
Table 6. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Gastrointestinal OTC Drugs Product and Services
Table 10. Pfizer Gastrointestinal OTC Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson Major Business
Table 13. Johnson & Johnson Gastrointestinal OTC Drugs Product and Services
Table 14. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Bayer Basic Information, Manufacturing Base and Competitors
Table 16. Bayer Major Business
Table 17. Bayer Gastrointestinal OTC Drugs Product and Services
Table 18. Bayer Gastrointestinal OTC Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Procter & Gamble Basic Information, Manufacturing Base and Competitors
Table 20. Procter & Gamble Major Business
Table 21. Procter & Gamble Gastrointestinal OTC Drugs Product and Services
Table 22. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Perrigo Basic Information, Manufacturing Base and Competitors
Table 24. Perrigo Major Business
Table 25. Perrigo Gastrointestinal OTC Drugs Product and Services
Table 26. Perrigo Gastrointestinal OTC Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Abbott Basic Information, Manufacturing Base and Competitors
Table 28. Abbott Major Business
Table 29. Abbott Gastrointestinal OTC Drugs Product and Services
Table 30. Abbott Gastrointestinal OTC Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Major Business
Table 33. Sanofi Gastrointestinal OTC Drugs Product and Services
Table 34. Sanofi Gastrointestinal OTC Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Teva Pharmaceutical Major Business
Table 37. Teva Pharmaceutical Gastrointestinal OTC Drugs Product and Services
Table 38. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Nestle Basic Information, Manufacturing Base and Competitors
Table 40. Nestle Major Business
Table 41. Nestle Gastrointestinal OTC Drugs Product and Services
Table 42. Nestle Gastrointestinal OTC Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer Ingelheim Major Business
Table 45. Boehringer Ingelheim Gastrointestinal OTC Drugs Product and Services
Table 46. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Reckitt Benckiser Basic Information, Manufacturing Base and Competitors
Table 48. Reckitt Benckiser Major Business
Table 49. Reckitt Benckiser Gastrointestinal OTC Drugs Product and Services
Table 50. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 52. Purdue Pharma Major Business
Table 53. Purdue Pharma Gastrointestinal OTC Drugs Product and Services
Table 54. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Gastrointestinal OTC Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 56. Global Gastrointestinal OTC Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Gastrointestinal OTC Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Gastrointestinal OTC Drugs Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 59. Head Office and Gastrointestinal OTC Drugs Production Site of Key Manufacturer
Table 60. Gastrointestinal OTC Drugs New Entrant and Capacity Expansion Plans
Table 61. Gastrointestinal OTC Drugs Mergers & Acquisitions in the Past Five Years
Table 62. Global Gastrointestinal OTC Drugs Sales by Region (2017-2022) & (K Pcs)
Table 63. Global Gastrointestinal OTC Drugs Sales by Region (2023-2028) & (K Pcs)
Table 64. Global Gastrointestinal OTC Drugs Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Gastrointestinal OTC Drugs Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
Table 67. Global Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
Table 68. Global Gastrointestinal OTC Drugs Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Gastrointestinal OTC Drugs Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Gastrointestinal OTC Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 71. Global Gastrointestinal OTC Drugs Price by Type (2023-2028) & (USD/Pcs)
Table 72. Global Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
Table 73. Global Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
Table 74. Global Gastrointestinal OTC Drugs Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Gastrointestinal OTC Drugs Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Gastrointestinal OTC Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 77. Global Gastrointestinal OTC Drugs Price by Application (2023-2028) & (USD/Pcs)
Table 78. North America Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Pcs)
Table 79. North America Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Pcs)
Table 80. North America Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
Table 83. North America Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
Table 84. North America Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
Table 85. North America Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
Table 86. Europe Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Pcs)
Table 87. Europe Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Pcs)
Table 88. Europe Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
Table 91. Europe Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
Table 92. Europe Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
Table 93. Europe Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
Table 94. Asia-Pacific Gastrointestinal OTC Drugs Sales by Region (2017-2022) & (K Pcs)
Table 95. Asia-Pacific Gastrointestinal OTC Drugs Sales by Region (2023-2028) & (K Pcs)
Table 96. Asia-Pacific Gastrointestinal OTC Drugs Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Gastrointestinal OTC Drugs Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
Table 99. Asia-Pacific Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
Table 100. Asia-Pacific Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
Table 101. Asia-Pacific Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
Table 102. South America Gastrointestinal OTC Drugs Sales by Country (2017-2022) & (K Pcs)
Table 103. South America Gastrointestinal OTC Drugs Sales by Country (2023-2028) & (K Pcs)
Table 104. South America Gastrointestinal OTC Drugs Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Gastrointestinal OTC Drugs Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
Table 107. South America Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
Table 108. South America Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
Table 109. South America Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
Table 110. Middle East & Africa Gastrointestinal OTC Drugs Sales by Region (2017-2022) & (K Pcs)
Table 111. Middle East & Africa Gastrointestinal OTC Drugs Sales by Region (2023-2028) & (K Pcs)
Table 112. Middle East & Africa Gastrointestinal OTC Drugs Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Gastrointestinal OTC Drugs Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Gastrointestinal OTC Drugs Sales by Type (2017-2022) & (K Pcs)
Table 115. Middle East & Africa Gastrointestinal OTC Drugs Sales by Type (2023-2028) & (K Pcs)
Table 116. Middle East & Africa Gastrointestinal OTC Drugs Sales by Application (2017-2022) & (K Pcs)
Table 117. Middle East & Africa Gastrointestinal OTC Drugs Sales by Application (2023-2028) & (K Pcs)
Table 118. Gastrointestinal OTC Drugs Raw Material
Table 119. Key Manufacturers of Gastrointestinal OTC Drugs Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Gastrointestinal OTC Drugs Typical Distributors
Table 123. Gastrointestinal OTC Drugs Typical Customers
List of Figures
Figure 1. Gastrointestinal OTC Drugs Picture
Figure 2. Global Gastrointestinal OTC Drugs Revenue Market Share by Type in 2021
Figure 3. Laxatives
Figure 4. Anti-Flatulents
Figure 5. H2-Antaginists
Figure 6. Anti-Diarrheals
Figure 7. PPIs
Figure 8. Anti-Emetics
Figure 9. Other
Figure 10. Global Gastrointestinal OTC Drugs Revenue Market Share by Application in 2021
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Global Gastrointestinal OTC Drugs Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 15. Global Gastrointestinal OTC Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Gastrointestinal OTC Drugs Sales (2017-2028) & (K Pcs)
Figure 17. Global Gastrointestinal OTC Drugs Price (2017-2028) & (USD/Pcs)
Figure 18. Global Gastrointestinal OTC Drugs Production Capacity (2017-2028) & (K Pcs)
Figure 19. Global Gastrointestinal OTC Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Gastrointestinal OTC Drugs Market Drivers
Figure 21. Gastrointestinal OTC Drugs Market Restraints
Figure 22. Gastrointestinal OTC Drugs Market Trends
Figure 23. Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturer in 2021
Figure 24. Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturer in 2021
Figure 25. Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Gastrointestinal OTC Drugs Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Gastrointestinal OTC Drugs Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2017-2028)
Figure 29. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2017-2028)
Figure 30. North America Gastrointestinal OTC Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Europe Gastrointestinal OTC Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Gastrointestinal OTC Drugs Revenue (2017-2028) & (USD Million)
Figure 33. South America Gastrointestinal OTC Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Gastrointestinal OTC Drugs Revenue (2017-2028) & (USD Million)
Figure 35. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
Figure 36. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2017-2028)
Figure 37. Global Gastrointestinal OTC Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 38. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
Figure 39. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2017-2028)
Figure 40. Global Gastrointestinal OTC Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 41. North America Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
Figure 42. North America Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
Figure 43. North America Gastrointestinal OTC Drugs Sales Market Share by Country (2017-2028)
Figure 44. North America Gastrointestinal OTC Drugs Revenue Market Share by Country (2017-2028)
Figure 45. United States Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
Figure 49. Europe Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
Figure 50. Europe Gastrointestinal OTC Drugs Sales Market Share by Country (2017-2028)
Figure 51. Europe Gastrointestinal OTC Drugs Revenue Market Share by Country (2017-2028)
Figure 52. Germany Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Gastrointestinal OTC Drugs Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Gastrointestinal OTC Drugs Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Gastrointestinal OTC Drugs Revenue Market Share by Region (2017-2028)
Figure 61. China Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
Figure 68. South America Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
Figure 69. South America Gastrointestinal OTC Drugs Sales Market Share by Country (2017-2028)
Figure 70. South America Gastrointestinal OTC Drugs Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Gastrointestinal OTC Drugs Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Gastrointestinal OTC Drugs Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Gastrointestinal OTC Drugs Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Gastrointestinal OTC Drugs Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Gastrointestinal OTC Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Gastrointestinal OTC Drugs in 2021
Figure 82. Manufacturing Process Analysis of Gastrointestinal OTC Drugs
Figure 83. Gastrointestinal OTC Drugs Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
